How do I buy Cognition Therapeutics (CGTX) stock?

You can purchase shares of Cognition Therapeutics (NASDAQ:CGTX) through any online brokerage.View our list of the best stock brokerages

Who are Cognition Therapeutics (CGTX) competitors?

Other companies in Cognition Therapeutics’s space includes: Atea Pharmaceuticals Inc (NASDAQ:AVIR), MediWound Ltd (NASDAQ:MDWD), Cumberland Pharmaceuticals Inc (NASDAQ:CPIX), CalciMedica Inc (NASDAQ:CALC) and Rani Therapeutics Holdings Inc (NASDAQ:RANI).

What is the forecast, or price target, for Cognition Therapeutics (CGTX) stock?

Cognition Therapeutics has a consensus price target of $5.79.

What is the current price for Cognition Therapeutics (CGTX)?

The stock price for Cognition Therapeutics (NASDAQ: CGTX) is $1.43 last updated January 22, 2026 at 4:36 PM EST.

Does Cognition Therapeutics (CGTX) pay a dividend?

There are no upcoming dividends for Cognition Therapeutics.

When is Cognition Therapeutics (NASDAQ:CGTX) reporting earnings?

Cognition Therapeutics does not have any upcoming earnings scheduled.

Is Cognition Therapeutics (CGTX) going to split?

There is no upcoming split for Cognition Therapeutics.

What sector and industry does Cognition Therapeutics (CGTX) operate in?

Cognition Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Cognition Therapeutics (CGTX) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Pharmaceuticals

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its ...

Comments